← Leaderboards
Alan A Arslan
New York University School Of Medicine
$1,978,829
Attributed
$2,325,895
Total exposure
7
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $594.4K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
CDC$1,440,516 · 3
NIH$885,379 · 4
By mechanism
R21$1,127,759 · 3
U01$694,133 · 1
R03$504,003 · 3
Top collaborators
- Yongzhao Shao2 shared
Most similar at New York University School Of Medicine
Same institution · by research overlap
- Anne Zeleniuch-Jacquotte$14,853,206
- Charles Lockwood$12,124,373
- Roy E. Shore$4,559,031
Others in their field
Top investigators on “Women'S Health”
- Chanza Baytop · Westat, Inc.$271,217,917
- Wafaa M. El-Sadr · Columbia University Health Sciences$240,499,512
- Sharon A Nachman · Johns Hopkins University$213,337,729
- Myron S Cohen · Family Health International$206,489,087
- Barbara Driver · Westat, Inc.$200,651,985
- Carol Nesel · Westat$188,148,170
Research focus
Women'S HealthBiomarkerClinical ResearchCell ProliferationCancer RiskStatistics /BiometryNeoplasm /Cancer EpidemiologyPregnancyHuman SubjectFemaleCell DifferentiationOvary NeoplasmsHuman Pregnant SubjectHispanic AmericansAfrican AmericanHormone Regulation /Control MechanismImmunologic Assay /TestCytoprotectionAlpha FetoproteinCancer PreventionCaucasian AmericanAsiansCd95 MoleculeAge At Pregnancy
Grant awards (15)
Integrated analysis of cancer risk and mortality in WTC survivors$348,019
U01 · FY2025 · OH
Tissue Molecular Profiles in WTC-exposed Community$246,387
R21 · FY2025 · OH · contact PI
Integrated analysis of cancer risk and mortality in WTC survivors$346,114
U01 · FY2024 · OH
DNA Methylation Profiles and Breast Cancer among WTC Survivors$253,814
R21 · FY2022 · OH · contact PI
DNA Methylation Profiles and Breast Cancer among WTC Survivors$246,182
R21 · FY2021 · OH · contact PI
Inflammatory Markers in Circulation and Ovarian Cancer Risk$190,688
R21 · FY2009 · CA · contact PI
Inflammatory Markers in Circulation and Ovarian Cancer Risk$190,688
R21 · FY2008 · CA · contact PI
Serum Vitamin D, Genetic Polymorphisms &Ovarian Cancer$84,500
R03 · FY2005 · CA
Serum Vitamin D, Genetic Polymorphisms &Ovarian Cancer$82,223
R03 · FY2004 · CA
Biomarkers of Ovarian Cancer Risk: A Prospective Study$42,250
R03 · FY2004 · CA
Pregnancy Hormonal Profile/Biomarker Breast Cancer Risk$42,250
R03 · FY2004 · CA
Pregnancy Hormonal Profile/Biomarker Breast Cancer Risk$42,229
R03 · FY2003 · CA
Biomarkers of Ovarian Cancer Risk: A Prospective Study$42,198
R03 · FY2003 · CA
Pregnancy Hormonal Profile/Biomarker Breast Cancer Risk$84,208
R03 · FY2002 · CA
Biomarkers of Ovarian Cancer Risk: A Prospective Study$84,145
R03 · FY2002 · CA